EUCTR2006-000062-37-DE进行中（未招募）不适用
A 14 day monocentric, double-blind, randomized phase III clinical study to investigate the antimicrobial efficacy and local tolerability of an antiseptic mouth rinse solution (Stellisept mucosa, containing 0.1 % octenidine dihydrochloride)with daily applications in comparison to a reference product (Octenisept®) in a panel of 44 healthy male and female volunteers
BODE Chemie GmbH & Co.0 个研究点目标入组 44 人开始时间: 2006年3月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- male and female healthy volunteers
- •- 18-65 years of age
- •- informed consent
- •- negative pregnancy test
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- age under 18 or over 65
- •- pregnancy or lactating mother
研究者
相似试验
进行中（未招募）
1 期
A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin® Peanut in peanut-allergic young children 1-3 years of age (EPITOPE study)Peanut allergyMedDRA version: 20.1Level: LLTClassification code 10034202Term: Peanut allergySystem Organ Class: 100000004870EUCTR2016-003679-23-IEDBV TECHNOLOGIES S.A.400
已完成
3 期
A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin Peanut in peanut-allergic young children 1-3 years of age (EPITOPE study)Peanut-allergy10001708NL-OMON49306DBV Technologies S.A.20
进行中（未招募）
1 期
A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin® Peanut in peanut-allergic young children 1-3 years of age (EPITOPE study)EUCTR2016-003679-23-NLDBV TECHNOLOGIES S.A.400
进行中（未招募）
1 期
A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin® Peanut in peanut-allergic young children 1-3 years of age (EPITOPE study)Peanut allergyMedDRA version: 20.1Level: LLTClassification code 10034202Term: Peanut allergySystem Organ Class: 100000004870EUCTR2016-003679-23-FRDBV TECHNOLOGIES S.A.400
进行中（未招募）
1 期
Efficacy and safety of Viaskin Peanut in peanut-allergic childreEUCTR2015-002461-37-DEDBV Technologies330